Development of Novel Epigenetic Anti-Cancer Therapy Targeting TET Proteins

Hyejin Kim, Inkyung Jung, Chan Hyeong Lee, Jungeun An, Myunggon Ko

Open source

DOI
10.3390/ijms242216375
Published
2023-11-15
Container
International Journal of Molecular Sciences
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ijms242216375,
  title = {Development of Novel Epigenetic Anti-Cancer Therapy Targeting TET Proteins},
  author = {Hyejin Kim and Inkyung Jung and Chan Hyeong Lee and Jungeun An and Myunggon Ko},
  year = {2023},
  journal = {International Journal of Molecular Sciences},
  doi = {10.3390/ijms242216375},
  url = {https://doi.org/10.3390/ijms242216375}
}

RIS

TY  - JOUR
TI  - Development of Novel Epigenetic Anti-Cancer Therapy Targeting TET Proteins
AU  - Hyejin Kim
AU  - Inkyung Jung
AU  - Chan Hyeong Lee
AU  - Jungeun An
AU  - Myunggon Ko
PY  - 2023
JO  - International Journal of Molecular Sciences
DO  - 10.3390/ijms242216375
UR  - https://doi.org/10.3390/ijms242216375
ER  - 

APA

Kim, H., Jung, I., Lee, C. H., An, J., & Ko, M. (2023). Development of Novel Epigenetic Anti-Cancer Therapy Targeting TET Proteins. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242216375

Source records